SWOG
- Country
- đēđ¸United States
- Ownership
- Private, Subsidiary
- Established
- 1956-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.swog.org
S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2006-09-15
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 68
- Registration Number
- NCT00376961
- Locations
- đēđ¸
Tammy Walker Cancer Center at Salina Regional Health Center, Salina, Kansas, United States
đēđ¸Alaska Regional Hospital Cancer Center, Anchorage, Alaska, United States
đēđ¸Providence Cancer Center, Anchorage, Alaska, United States
S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
- Conditions
- LymphomaUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 66
- Registration Number
- NCT00352443
- Locations
- đēđ¸
University of California Davis Cancer Center, Sacramento, California, United States
đēđ¸University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
đēđ¸University Cancer Center at University of Washington Medical Center, Seattle, Washington, United States
S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
- First Posted Date
- 2006-06-15
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 36
- Registration Number
- NCT00337168
- Locations
- đēđ¸
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
đēđ¸CCOP - Montana Cancer Consortium, Billings, Montana, United States
đēđ¸Charles B. Eberhart Cancer Center at DeKalb Medical Center, Decatur, Georgia, United States
S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery
- Conditions
- Gastric Cancer
- Interventions
- First Posted Date
- 2006-06-12
- Last Posted Date
- 2012-08-17
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 7
- Registration Number
- NCT00335959
- Locations
- đēđ¸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
đēđ¸Munson Medical Center, Traverse City, Michigan, United States
đēđ¸Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler, Savannah, Georgia, United States
S0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Conditions
- Kidney Cancer
- Interventions
- Biological: CNTO 328
- First Posted Date
- 2006-04-06
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00311545
S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone
- Conditions
- Breast CancerHypercalcemia of MalignancyMetastatic CancerPain
- Interventions
- First Posted Date
- 2006-03-13
- Last Posted Date
- 2013-11-13
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00301886
S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2013-01-04
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 24
- Registration Number
- NCT00288054
- Locations
- đēđ¸
Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, United States
đēđ¸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
đēđ¸Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus, Boca Raton, Florida, United States
S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT
- Conditions
- Prostate Cancer
- Interventions
- Other: Follow-up
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2015-09-30
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 961
- Registration Number
- NCT00288106
- Locations
- đēđ¸
Mount Carmel Health - West Hospital, Columbus, Ohio, United States
đēđ¸Doctors Hospital at Ohio Health, Columbus, Ohio, United States
đēđ¸Virginia Piper Cancer Institute at Abbott - Northwestern Hospital, Minneapolis, Minnesota, United States
S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx
- Conditions
- Head and Neck Cancer
- Interventions
- First Posted Date
- 2005-12-22
- Last Posted Date
- 2012-10-04
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 6
- Registration Number
- NCT00268372
- Locations
- đēđ¸
John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, United States
đēđ¸Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, United States
đēđ¸University of Mississippi Medical Center, Jackson, Mississippi, United States
S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- First Posted Date
- 2005-12-15
- Last Posted Date
- 2012-11-01
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 27
- Registration Number
- NCT00265785
- Locations
- đēđ¸
NEA Medical Center - Stadium Boulevard, Jonesboro, Arkansas, United States
đēđ¸CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States
đēđ¸St. John's Regional Health Center, Springfield, Missouri, United States